AstraZeneca LP Discontinues LEXXEL (enalapril maleate-felodipine ER) Tablets

Published: Dec 28, 2007

San Francisco, Calif. – AstraZeneca announces it has no further plans to manufacture or distribute LEXXEL (enalapril maleate-felodipine ER) Tablets after July 31, 2008.

LEXXEL is indicated for the treatment of hypertension. For more information, please contact AstraZeneca LP Contact Corporate Information Center at 800-236-9933.

To view a complete list of discontinued drugs from the FDA, visit: http://www.fda.gov/cder/drug/shortages/default.htm#disc

Contact Suvarna Bhatt at sbhatt@biospace.com.

Back to news